<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04116996</url>
  </required_header>
  <id_info>
    <org_study_id>17-010112</org_study_id>
    <nct_id>NCT04116996</nct_id>
  </id_info>
  <brief_title>Globus Pallidus Stimulation to Treat Insomnia</brief_title>
  <acronym>GPS-I</acronym>
  <official_title>Stimulation of the External Pallidal Segment for Insomnia in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are to determine if turning on an additional unilateral DBS (deep brain
      stimulation) electrode with stimulation to the globus pallidus externa (GPe) region of the
      brain will improve insomnia (sleep).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Insomnia Severity Index</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Change in self-reported insomnia severity index questionnaire score, using a total score scale of 0-7 is no clinically significant insomnia, 8-14 is subthreshold insomnia, 15-21 is clinical insomnia (moderate severity), 22-28 is Clinical insomnia (severe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Parkinson's Sleep Scale (PDSS)</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Change in self-reported Parkinson's Sleep Scale (PDSS) questionnaire, using a scale of 0 is always and 10 as never</description>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Parkinson Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DEEP BRAIN STIMULATION</intervention_name>
    <description>NEUROMODULATION</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  40-80 years of age

          -  Symptomatic with Parkinsonism for 7-20 years

          -  Severe insomnia based on ISI score

        Exclusion Criteria:

          -  Clinically significant dementia (MMSE &lt;23)

          -  Hoehn &amp; Yahr [Hoehn, 1967 #1839] stage I or V disease

          -  Other significant neurological or psychiatric disease

          -  Previous pallidotomy or thalamotomy

          -  Previous placement of other implantable devices

          -  Secondary parkinsonism (non-idiopathic parkinsonism)

          -  Inability to travel to Jacksonville for post-operative study visits

          -  Severe sleep apnea

          -  Insomnia due to pain or untreated mood disorder

          -  Contraindications to 3T MRI

          -  Circadian rhythm sleep disorders.

          -  Current use of hypnotics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo Castillo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo R Castillo, MD</last_name>
      <phone>904-953-2000</phone>
      <email>castillo.pablo@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 2, 2019</study_first_submitted>
  <study_first_submitted_qc>October 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2019</study_first_posted>
  <last_update_submitted>October 3, 2019</last_update_submitted>
  <last_update_submitted_qc>October 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Pablo Castillo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

